Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 14844

1.

Prevalence of Human Papillomavirus (HPV) in upper respiratory tract mucosa in a group of pre-school children.

Szydłowski J, Jonczyk-Potoczna K, Pucher B, Buraczyńska-Andrzejewska B, Prauzińska M, Kolasińska-Lipńska J, Krauss H, Piątek J, Żukiewicz-Sobczak W.

Ann Agric Environ Med. 2014 Nov 26;21(4):822-4. doi: 10.5604/12321966.1129940.

PMID:
25528927
[PubMed - in process]
2.

In-vitro assessment of the effect of vaccine-targeted human papillomavirus (HPV) depletion on detection of non-vaccine HPV types: implications for post-vaccine surveillance studies.

Cornall AM, Phillips S, Cummins E, Garland SM, Tabrizi SN.

J Virol Methods. 2014 Dec 17. pii: S0166-0934(14)00473-X. doi: 10.1016/j.jviromet.2014.12.007. [Epub ahead of print]

PMID:
25528202
[PubMed - as supplied by publisher]
3.

Human papillomavirus 16/18 seroprevalence in unvaccinated women over 30 years with normal cytology and with high grade cervical abnormalities in Australia: results from an observational study.

Velentzis LS, Sitas F, O Connell DL, Brown J, Egger S, Sinha R, Banks E, Frazer IH, Canfell K.

BMC Infect Dis. 2014 Dec 21;14(1):676. [Epub ahead of print]

PMID:
25528152
[PubMed - as supplied by publisher]
Free Article
4.

Reliability of the Xpert HPV Assay to Detect High-Risk Human Papillomavirus DNA in a Colposcopy Referral Population.

Castle PE, Smith KM, Davis TE, Schmeler KM, Ferris DG, Savage AH, Gray JE, Stoler MH, Wright TC Jr, Ferenczy A, Einstein MH.

Am J Clin Pathol. 2015 Jan;143(1):126-33. doi: 10.1309/AJCP4Q0NSDHWIZGU.

PMID:
25511151
[PubMed - in process]
5.

Multiple human papillomavirus infections are highly prevalent in the anal canal of human immunodeficiency virus-positive men who have sex with men.

Méndez-Martínez R, Rivera-Martínez NE, Crabtree-Ramírez B, Sierra-Madero JG, Caro-Vega Y, Galván SC, de León D, García-Carrancá A.

BMC Infect Dis. 2014 Dec 16;14(1):671. [Epub ahead of print]

PMID:
25510243
[PubMed - as supplied by publisher]
Free PMC Article
6.

Human papillomavirus (HPV) is not the main cause of preinvasive and invasive cervical cancer among patients in Delta Region, Egypt.

Thabet M, Hemida R, Hasan M, Elshamy M, Elfaraash M, Emam M.

J Exp Ther Oncol. 2014;10(4):247-53.

PMID:
25509977
[PubMed - in process]
7.

Comparison of Hybribio GenoArray and Roche human papillomavirus (HPV) Linear Array for HPV genotyping in anal swab samples.

Low HC, Silver MI, Brown BJ, Leng CY, Blas MM, Gravitt PE, Woo YL.

J Clin Microbiol. 2014 Dec 10. pii: JCM.02274-14. [Epub ahead of print]

PMID:
25502520
[PubMed - as supplied by publisher]
8.

The preliminary study of p53 codon 72 polymorphism and risk of cervical carcinoma in Gabonese women.

Assoumou SZ, Boumba AL, Ndjoyi-Mbiguino A, Khattabi A, Ennaji MM.

Med Oncol. 2015 Jan;32(1):281. doi: 10.1007/s12032-014-0281-4. Epub 2014 Dec 12.

PMID:
25502079
[PubMed - in process]
9.

Human papillomavirus prevalence and type distribution among women attending routine gynecological examinations in Saudi Arabia.

AlObaid A, Al-Badawi IA, Al-Kadri H, Gopala K, Kandeil W, Quint W, Al-Aker M, DeAntonio R.

BMC Infect Dis. 2014 Dec 14;14(1):643. [Epub ahead of print]

PMID:
25496614
[PubMed - as supplied by publisher]
Free PMC Article
10.

Prevalence of human papillomaviruses in the healthy oral mucosa of women with high-grade squamous intra-epithelial lesion and of their partners as compared to healthy controls.

Tatár TZ, Kis A, Szabó E, Czompa L, Boda R, Tar I, Szarka K.

J Oral Pathol Med. 2014 Dec 14. doi: 10.1111/jop.12302. [Epub ahead of print]

PMID:
25495524
[PubMed - as supplied by publisher]
11.

Immune therapy for human papillomaviruses-related cancers.

Rosales R, Rosales C.

World J Clin Oncol. 2014 Dec 10;5(5):1002-19. doi: 10.5306/wjco.v5.i5.1002. Review.

PMID:
25493236
[PubMed]
Free PMC Article
12.

[Current problems and recent advances in the molecular diagnosis of genital human papillomavirus infections].

Sahiner F.

Mikrobiyol Bul. 2014 Oct;48(4):689-706. Turkish.

PMID:
25492665
[PubMed - in process]
13.

Immunoprevention of human papillomavirus-associated malignancies.

Wang JW, Hung CF, Huh WK, Trimble CL, Roden RB.

Cancer Prev Res (Phila). 2014 Dec 8. pii: canprevres.0311.2014. [Epub ahead of print]

PMID:
25488410
[PubMed - as supplied by publisher]
14.

A population-based observational study comparing Cervista and Hybrid Capture 2 methods: improved relative specificity of the Cervista assay by increasing its cut-off.

Boehmer G, Wang L, Iftner A, Holz B, Haedicke J, von Wasielewski R, Martus P, Iftner T.

BMC Infect Dis. 2014 Dec 9;14(1):674. [Epub ahead of print]

PMID:
25487281
[PubMed - as supplied by publisher]
Free Article
15.

Role of Cdk1 in DNA damage-induced G1 checkpoint abrogation by the human papillomavirus E7 oncogene.

Fan X, Chen JJ.

Cell Cycle. 2014 Oct 15;13(20):3249-59. doi: 10.4161/15384101.2014.953879.

PMID:
25485505
[PubMed - in process]
16.

Primary human papillomavirus DNA screening for cervical cancer prevention: Can the screening interval be safely extended?

Vink MA, Bogaards JA, Meijer CJ, Berkhof J.

Int J Cancer. 2014 Dec 6. doi: 10.1002/ijc.29381. [Epub ahead of print]

PMID:
25484263
[PubMed - as supplied by publisher]
17.

Comparison of long-term immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine in healthy women aged 18-45 years: end-of-study analysis of a Phase III randomized trial.

Takacs P, Chatterjee A, Sperling R, Chakhtoura N, Blatter M, Lalezari J, David MP, Lin L, Struyf F, Dubin G, Einstein MH.

Hum Vaccin Immunother. 2014 Nov 1:e36121. [Epub ahead of print]

PMID:
25483701
[PubMed - as supplied by publisher]
18.

Comparative humoral and cellular immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine in healthy women aged 18-45 years: Follow-up through Month 48 in a Phase III randomized study.

Levin MJ, Chatterjee A, Chakhtoura N, Takacs P, Catteau G, Dessy F, Moris P, Lin L, Struyf F, Dubin G, Einstein MH.

Hum Vaccin Immunother. 2014 Nov 1:e36117. [Epub ahead of print]

PMID:
25483700
[PubMed - as supplied by publisher]
19.

Chlamydia trachomatis prevalence and chlamydial/HPV co-infection among HPV-unvaccinated young Italian females with normal cytology.

Panatto D, Amicizia D, Bianchi S, Frati ER, Zotti CM, Lai PL, Domnich A, Colzani D, Gasparini R, Tanzi E.

Hum Vaccin Immunother. 2014 Aug 28:e36163. [Epub ahead of print]

PMID:
25483545
[PubMed - as supplied by publisher]
20.

Anti-tumor effects of genetic vaccines against HPV major oncogenes.

Cordeiro MN, Paolini F, Massa S, Curzio G, Illiano E, Duarte Silva AJ, Franconi R, Bissa M, Morghen CD, de Freitas AC, Venuti A.

Hum Vaccin Immunother. 2014 Aug 6:e34303. [Epub ahead of print]

PMID:
25483514
[PubMed - as supplied by publisher]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk